Search results
Author(s):
John J Atherton
,
Annabel Hickey
Added:
3 years ago
The prevalence of heart failure (HF) continues to rise, driven by an ageing population, increasing rates of obesity and diabetes, and better survival in patients with cardiovascular disease.1 While HF is associated with substantial morbidity and mortality, a number of treatments have been shown to improve outcomes in large-scale randomised controlled trials (RCT), including pharmacological…
View more
Author(s):
Mark Sweeney
,
Angela Yiu
,
Alexander Lyon
Added:
3 years ago
Cancer and the anti-cancer treatments prescribed by oncologists have long been known to have significant effects on muscle, causing a catabolic muscle wasting state and resulting in widespread and progressive atrophy of most muscle groups.1 This process contributes significantly to the cancer cachexia seen in up to 80% of all patients with cancer, resulting in progressive weight loss, loss of…
View more
Author(s):
Wan Xian Chan
,
Weiqin Lin
,
Raymond Ching Chiew Wong
Added:
3 years ago
Southeast Asian nations are increasingly facing a higher burden of cardiovascular risk factors,1 which in turn correlate with a propensity towards cardiac-related diseases including heart failure (HF). In Singapore, HF is the most common cardiac cause of hospitalisation, accounting for 17 % of all cardiac admissions2 In 2015, public hospitals recorded in excess of 5,700 unique HF admissions.3 The…
View more
Author(s):
Yih-Kai Chan
,
Alice M David
,
Caitlyn Mainland
,
et al
Added:
3 years ago
Primarily due to significant treatment advancements to prevent previously fatal acute cardiac events, the burden of heart failure (HF), characterised by chronic symptoms, acute hospitalisations and premature mortality, continues to rise.1,2 Latest expert guidelines3,4 confirmed by meta-analyses5,6 support the application of multidisciplinary HF management programs to improve health outcomes…
View more
Author(s):
David R Thompson
,
Chantal F Ski
,
Alexander M Clark
,
et al
Added:
1 year ago
Author(s):
Sarah H Cross
,
Arif H Kamal
,
Donald H Taylor Jr
,
et al
Added:
3 years ago
Heart failure (HF) is estimated to affect 26 million people worldwide and is responsible for an annual global economic burden of US$108 billion.1,2 An ageing population and a reduction in mortality from other conditions such as acute MI are expected to result in an increased HF prevalence throughout much of the world.1,3–6 The prevalence of HF has particularly increased among those aged 85 years…
View more
Author(s):
Eilidh Hill
,
Jackie Taylor
Added:
3 years ago
In developed countries, it is estimated that 1–2 % of the adult population has heart failure (HF), with the prevalence increasing to more than 10 % in those aged >70 years.1 Despite advances in therapies for heart failure with reduced ejection fraction (HFrEF), it remains a condition associated with significant morbidity and mortality, punctuated by episodes of unplanned hospitalisation.2
HF…
View more
Author(s):
Rekha V Thammana
,
Sarah J Goodlin
Added:
1 year ago
HFpEF in Primary Care
Author(s):
Simon Stewart
,
Amy R Stewart
,
Laura Waite
,
et al
Added:
2 years ago
Article
Author(s):
Ovidiu Chioncel
,
Sean P Collins
,
Stephen J Greene
,
et al
Added:
3 years ago
Hospitalisation is a critical event in the clinical course of heart failure (HF) and despite relatively rapid relief of symptoms, hospitalisation is followed by an increased risk of death and re-hospitalisation.1 While performance measures have been developed in the last few years with the intent of improving post-discharge outcomes, post-discharge mortality rates remain unchanged or have…
View more